Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries. The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired. The deal has already been approved by the boards of directors from both companies. Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery. Shockwave’s technology is used to treat coronary artery and peripheral artery disease. The company’s revenue jumped 49% last year to $730 million. |
Madonna, 65, flashes her cleavage while leaning over a Bible with a man next to her as she covers ReKylie Kelce celebrates her sixth wedding anniversary with husband JasonMookie Betts ties career high with 5 hits as Dodgers beat Nationals 6Russia begins withdrawing peacekeeping forces from Karabakh, now under full Azerbaijan controlTyler Myers, Thatcher Demko help Canucks beat Flames 4Timothee Chalamet carries a guitar case as he films scenes with coSenate to convene Mayorkas impeachment trial as Democrats plot quick dismissalThe Taliban suspend two TV stations in Afghanistan for neglecting Islamic and national valuesEU leaders want to talk competitiveness. Middle East tensions and Ukraine top their summit listLynn earns his first win in second stint with Cards, who beat A's before season